Please login to the form below
Kurve launches nasal drug delivery blog
The first blog to address issues related to nasal drug delivery formulation, research, delivery and devices is launched by US nasal drug delivery specialist, Kurve Technology
The first blog to address issues related to nasal drug delivery formulation, research, delivery and devices has been launched by US nasal drug delivery specialist, Kurve Technology.
The blog can be found on www.nasaldrugdeliveryblog.com and invites scientists, researchers and pharmaceutical executives to exchange and comment on clinical research, recently-published journal articles, events and conferences and thought-provoking posts on systemic, topical and nose-to-brain delivery.
Non-promotional blog entries are authored by the executive team of Kurve Technology, as well as guest contributors.
Marc Giroux, CEO of Kurve Technology, said: ìOur aim was to create an online forum for open communication in the nasal delivery industry. Now academic researchers, pharmaceutical industry managers, and device professionals can interact every day rather then wait for the next conference or event. Pharmaceutical and trade media can also stay abreast of industry developments via the blog.î
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director - Med Comms Agency
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
- AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
- Building meaningful customer engagement through data-driven digital insights
- Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
- CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Gene Editing and Precision Medicine: The Future of Healthcare?
PMHub
TRIDUCIVE
Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...
Latest intelligence
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
Quick links
Infographics
